0002111089-26-000001.txt : 20260731 0002111089-26-000001.hdr.sgml : 20260731 20260731140653 ACCESSION NUMBER: 0002111089-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260731 DATE AS OF CHANGE: 20260731 EFFECTIVENESS DATE: 20260731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mangrove Therapeutics Inc. CENTRAL INDEX KEY: 0002111089 ORGANIZATION NAME: EIN: 412600694 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-592823 FILM NUMBER: 261227739 BUSINESS ADDRESS: STREET 1: 2108 N ST STREET 2: STE C CITY: SACRAMENTO STATE: CA ZIP: 95816 BUSINESS PHONE: (650) 485-3618 MAIL ADDRESS: STREET 1: 2108 N ST STREET 2: STE C CITY: SACRAMENTO STATE: CA ZIP: 95816 D 1 primary_doc.xml X0708 D LIVE 0002111089 Mangrove Therapeutics Inc. 2108 N ST STE C SACRAMENTO CA CALIFORNIA 95816 (650) 485-3618 DELAWARE None None Corporation true 2025 Jin Li 2108 N St Ste C Sacramento CA CALIFORNIA 95816 Director Benjamin Zhiyi Chen 2108 N St Ste C Sacramento CA CALIFORNIA 95816 Executive Officer Director Chief Executive Officer (Interim) / President Alexander Simon Green 2108 N St Ste C Sacramento CA CALIFORNIA 95816 Executive Officer Chief Financial Officer Treasurer Biotechnology No Revenues 06b false 2026-07-21 false true Simple Agreement for Future Equity (SAFE) false 25000 5000000 2455000 2545000 false 9 0 0 0 false Mangrove Therapeutics Inc. Alexander Simon Green Alexander Simon Green Secretary 2026-07-31